Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family.

Clinical and Diagnostic Laboratory Immunology
J L DoranF E Nano

Abstract

The Mycobacterium tuberculosis H37Rv efpA gene encodes a putative efflux protein, EfpA, of 55,670 Da. The deduced EfpA protein was similar in secondary structure to Pur8, MmrA, TcmA, LfrA, EmrB, and other members of the QacA transporter family (QacA TF) which mediate antibiotic and chemical resistance in bacteria and yeast. The predicted EfpA sequence possessed all transporter motifs characteristic of the QacA TF, including those associated with proton-antiport function and the motif considered to be specific to exporters. The 1,590-bp efpA open reading frame was G+C rich (65%), whereas the 40-bp region immediately upstream had an A+T bias (35% G+C). Reverse transcriptase-PCR assays indicated that efpA was expressed in vitro and in situ. Putative promoter sequences were partially overlapped by the A+T-rich region and by a region capable of forming alternative secondary structures indicative of transcriptional regulation in analogous systems. PCR single-stranded conformational polymorphism analysis demonstrated that these upstream flanking sequences and the 231-bp, 5' coding region are highly conserved among both drug-sensitive and multiply-drug-resistant isolates of M. tuberculosis. The efpA gene was present in the slow-growing...Continue Reading

References

Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·O Lomovskaya, K Lewis
Aug 1, 1992·Current Opinion in Cell Biology·J K GriffithP J Henderson
Apr 1, 1992·Antimicrobial Agents and Chemotherapy·S B Levy
Jan 11, 1991·Methods in Enzymology·W R JacobsB R Bloom
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A A NeyfakhL B Chen
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jul 5, 1990·Journal of Molecular Biology·D G KnellerR Langridge
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·K L Strauch, J Beckwith
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·C R FriedmanL W Riley
Oct 1, 1994·Molecular Microbiology·Y Zhang, D Young
Feb 1, 1995·Journal of Bacteriology·L KremerC Locht
Oct 1, 1994·Trends in Microbiology·M C Roberts
May 1, 1994·Molecular Microbiology·S Bergh, S T Cole
Jun 1, 1994·Antimicrobial Agents and Chemotherapy·Y PangM C Roberts
Mar 25, 1994·Journal of Molecular Biology·B Persson, P Argos
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·N Honoré, S T Cole
Aug 1, 1993·Current Opinion in Cell Biology·P J Henderson
Jan 1, 1993·Trends in Biochemical Sciences·M D Marger, M H Saier
Jan 1, 1996·Journal of Bacteriology·V BalasubramanianW R Jacobs
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·H E TakiffW R Jacobs
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·K MikusováP J Brennan
Jun 1, 1996·Antimicrobial Agents and Chemotherapy·T C VictorK D Eisenach
Apr 1, 1996·Microbiology·Siv G E Andersson, Paul M Sharp

❮ Previous
Next ❯

Citations

Feb 22, 2001·Antimicrobial Agents and Chemotherapy·P E SilvaJ A Aínsa
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·I Chopra, M Roberts
Nov 24, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·M C Roberts
Jun 26, 2008·The Journal of Antimicrobial Chemotherapy·D M O'SullivanS H Gillespie
May 16, 2002·Periodontology 2000·Marilyn C Roberts
May 11, 2017·Frontiers in Microbiology·Mohammad J NasiriMohammad M Feizabadi
Jan 9, 2019·Frontiers in Microbiology·Diana MachadoMiguel Viveiros
Oct 31, 2012·Expert Review of Anti-infective Therapy·Miguel ViveirosLeonard Amaral
May 20, 2009·Antimicrobial Agents and Chemotherapy·G E LouwT C Victor
Jan 1, 2012·Pharmaceuticals·Jansy Passiflora SarathyEdmund Jon Deoon Lee
Dec 17, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Anuj Kumar GuptaVishnu Dutt Sharma
Jan 14, 2004·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Mar 13, 2014·Antimicrobial Agents and Chemotherapy·Philippa A BlackBavesh D Kana
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Xian-Zhi LiHiroshi Nikaido
Jul 14, 2018·Nature Reviews. Microbiology·Dijun DuBen F Luisi
Jan 28, 2006·FEMS Microbiology Reviews·Edda De RossiGiovanna Riccardi
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M WilsonG K Schoolnik
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M A MulderL M Steyn
Oct 10, 2002·Clinics in Chest Medicine·Joseph O Falkinham
Oct 13, 2021·FEMS Microbiology Reviews·Sille RemmMarkus A Seeger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.